Anti-Mouse CD178 (FasL) – Purified in vivo GOLD™ Functional Grade
Anti-Mouse CD178 (FasL) – Purified in vivo GOLD™ Functional Grade
Product No.: M351
Clone MFL3 Target CD178 Formats AvailableView All Product Type Monoclonal Antibody Alternate Names FasL, Fas Ligand, FasL, Apo-1 Ligand, CD95 Ligand, TNFSF6 Isotype IgG Applications B , FC , IF , in vivo |
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Armenian Hamster Recommended Dilution Buffer Immunogen B6 mouse FasL cDNA-transfected baby hamster kidney (B6 FasL/BHK) cells Product Concentration ≥ 5.0 mg/ml Endotoxin Level < 1.0 EU/mg as determined by the LAL method Purity ≥95% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day 2-8°C RRIDAB_2894121 Applications and Recommended Usage? Quality Tested by Leinco FC The suggested concentration for this CD178 antibody, clone MFL3, for staining cells in flow cytometry is ≤ 0.25 μg per 106 cells in a volume of 100 μl. Titration of the reagent is recommended for optimal performance for each application. Additional Applications Reported In Literature ? B IF Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone MFL3 recognizes an epitope on mouse FasL.
Background FasL antibody, clone AFS98, recognizes Fas ligand (FasL), also known as CD178, Apo-1 ligand, and CD95 ligand. FasL is a 40 kDa type II integral membrane protein that belongs to the tumor necrosis factor (TNF) superfamily. FasL is expressed by activated T cells and natural killer (NK cells)1-3. Binding of FasL to its receptor Fas (CD95, APO-1) induces apoptotic cell death in Fas-expressing target cells, contributing to anti-viral immunity. FasL also contributes to peripheral tolerance and the downregulation of immune responses through activation-induced autocrine and paracrine T cell death4. FasL is also found in the anterior chamber of the eye and on Sertoli cells in the testis, and is implicated in immune-privilege at these sites5,6. FasL also contributes to CD8 proliferation and neutrophil recruitment7,8. Soluble FasL (26 kDa) can be released following cleavage by metalloproteinases and block FasL-mediated signaling9. Fas/FasL-signaling is involved in the development of many human diseases, including autoimmunity and cancer10. Many human tumors over-express FasL, resulting in tumor infiltrating lymphocyte (TIL) apoptosis and immune evasion, which is associated with poor prognosis11-14. Antigen Distribution FasL is expressed on activated T cells, NK cells, the eye, and testis.
Ligand/Receptor Fas (CD95) PubMed NCBI Gene Bank ID Research Area Apoptosis . Cell Biology . Cell Death . Immunology . Neuroscience . Tumor Suppressors Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Applications of Clone MFL3 in In Vivo Mouse StudiesClone MFL3 is a hamster-derived monoclonal antibody that specifically targets mouse Fas Ligand (FasL, CD178, CD95 Ligand, TNFSF6), a type II transmembrane glycoprotein in the TNF superfamily. It is widely used in immunological research to study the biological roles of FasL in mice, including immune regulation, apoptosis, and immune evasion by tumors. Key Uses of MFL3 in Mouse Models
Technical Considerations
Summary Table: In Vivo Uses of Clone MFL3
ConclusionClone MFL3 is a versatile tool for in vivo mouse studies, enabling researchers to block FasL-mediated apoptosis, modulate immune responses, investigate tumor immune evasion, and study inflammation. Its specific reactivity, functional blocking capability, and availability in in vivo-grade formulations make it a valuable reagent for dissecting the complex roles of the Fas/FasL pathway in mouse models. I cannot find specific storage temperature information for the sterile packaged clone MFL3 in the provided search results. The search results contain storage temperature guidelines for various laboratory materials including Gibson Assembly kits, lambda vectors, ELISA kits, and general sterile supplies, but none specifically mention MFL3. General Guidelines for Sterile Packaged MaterialsWhile I cannot provide the exact storage temperature for MFL3, the search results do offer some general principles for storing sterile packaged items: Standard Storage Conditions: The storage area for packaged sterilized items should be well ventilated and protected against dust, moisture, insects, and temperature and humidity extremes. Common Laboratory Storage Temperatures: Many sterile biological materials are typically stored at standard laboratory temperatures such as:
RecommendationTo determine the correct storage temperature for your specific sterile packaged clone MFL3, I recommend:
Without access to the specific product information for MFL3, I cannot provide the definitive storage temperature, as different cloned materials may have varying storage requirements depending on their composition and intended use. Commonly Used Antibodies and Proteins with MFL3 in the LiteratureMFL3 is a well-known Armenian hamster monoclonal antibody targeting mouse Fas ligand (CD178). It is widely used in immunological research, particularly in studies investigating apoptosis, T cell activation, and immune regulation. Directly Co-Used Antibodies and Proteins
Other Contextual Uses in the LiteratureWhile the provided search results do not detail specific co-administration of MFL3 with Fc fusion proteins or albumin fusions, these protein classes are commonly used in antibody and protein therapeutic research, including studies on half-life extension and targeted delivery. However, there is no direct evidence that MFL3 is routinely used with these molecules in the cited literature. Summary Table
ConclusionsMFL3 is most commonly used in the literature alongside anti-CD3 antibodies and anti-Fas (CD95) antibodies for investigating T cell activation and apoptosis pathways, respectively. In flow cytometry, it is paired with a range of fluorescently labeled antibodies for detailed immune cell analysis. No standard co-use with Fc fusion proteins or albumin fusions is indicated in the provided literature. Clone MFL3 is a monoclonal antibody widely cited in scientific literature for its role in detecting and functionally blocking mouse Fas Ligand (FasL, CD178), a key mediator in apoptotic cell death and immune regulation. Key findings from citations of clone MFL3 in scientific literature include:
Summary of supporting details:
In sum, clone MFL3 citations underscore its importance as an investigative tool in murine FasL biology, immune regulation, and functional blocking of apoptosis in preclinical studies. References & Citations1. Okumura K., et al. (1994) Proc Natl Acad Sci USA. 91:4930–4934 2. Nagata S., et al. (1995) J Immunol. 154:3806–3813 3. Saito T., et al. (1995) J Exp Med. 181:1235–1238 4. Ferguson T A., et al. (1995) Science. 270:1189–1192 5. Duke R C., et al. (1995) Nature (London). 377:630–632 6. Fink PJ. (2000) J Immunol. 165(10):5537-43 7. Matsuzawa A., et al. (1998) J Immunol. 161: 4484–4488 8. Nagata S., et al. (1998) Nat Med. 4(1):31-6 9. Hueber AO., et al (2019) Cancers (Basel). 11(5):639 10. Kabelitz D., et al. (2000) Cancer Res. 60: 822–828 11. Giannarelli D., et al. (2000) Int J Cancer. 89: 127–132 12. Kanno H., et al. (2000) Br J Cancer. 82: 1446–1452. 13. Nagano H., et al. (Cancer) Br J Cancer. 82: 1211–1217 Technical ProtocolsCertificate of Analysis |
Formats Available
Prod No. | Description |
---|---|
M351 | |
M354 | |
M353 | |
M352 | |
M355 | |
M350 |
